WASICHANA WETU

Acceptability, feasibility and impact of oral HIV self-testing for partner testing among Kenyan adolescent girls aged 15-19 years: a randomized controlled trial

Forty percent of new HIV infections occur among adolescents and young women aged 15-24 years, 73% of whom live in sub-Saharan Africa. This is partly due to transactional sex with older men whose HIV status are unknown to the adolescent girls and young women. This pilot study was to explore whether the provision of multiple oral HIV self-test kits to sexually active adolescents aged 15-19 years can be used to facilitate partner testing. In the study, a randomized-controlled trial, preceded with qualitative and exploratory survey components to inform consenting process and to assess perceived ability of adolescent girls to offer self-test kits to their sexual partners was evaluated. The study will be conducted in 4 sequential phases, each phase informing the subsequent one:

  • understanding of the consenting document and process by participants who have not reached the legal age of consent (Phase I);

  • determining whether adolescent girls can offer oral HIV self-tests to their partners (Phase II);

  • assess whether oral self-testing improves uptake of HIV testing among partners of adolescent girls (Phase III);

  • document adverse events associated with offering oral self-testing to sexual partners of adolescents (Phase IV); and

  • qualitatively explore the experiences of adolescents in offering self-test kits to their partners (Phase V).

Study Contact: Kawango Agot (Email: kawango@impact-rdo.org )
Principal Investigator:Harsha Thirumurthy, PhD (University of North Carolina at Chapel Hill, NC, USA) and Kawango Agot, PhD, MPH (Impact Research and Development Organization, IRDO)
Co-Investigators:Gift-Noelle Wango, MPH, BSSN, CCRN (Centre for Disease Control and Prevention, Kisumu, Kenya), Sue Napierala Mavedzenge, PhD (RTI International, CA, USA), Samuel Masters, MPH, PhD(c) (PhD Student and research analyst, University of North Carolina at Chapel Hill, NC, USA), Spala Ohaga, MSc, PhD (Head of Programs, Impact Research and Development Organization, Kisumu, Kenya), Rose Oyoo, B.A, MA (Study Coordinator, Impact Research and Development Organization, Kisumu, Kenya)
Funding:University of North Carolina at Chapel Hill


Our Partners


CONTACT

Impact Research and Development Organization
Baring Road-Milimani
P.O. Box 9171-40141
Kisumu City
(254)-057-2020132
(254)-727-688550
(254)-738-772119
info@impact-rdo.org

Wasichana Wetu

The Research

WASICHANA WETU

Acceptability, feasibility and impact of oral HIV self-testing for partner testing among Kenyan adolescent girls aged 15-19 years: a randomized controlled trial

Forty percent of new HIV infections occur among adolescents and young women aged 15-24 years, 73% of whom live in sub-Saharan Africa. This is partly due to transactional sex with older men whose HIV status are unknown to the adolescent girls and young women. This pilot study was to explore whether the provision of multiple oral HIV self-test kits to sexually active adolescents aged 15-19 years can be used to facilitate partner testing. In the study, a randomized-controlled trial, preceded with qualitative and exploratory survey components to inform consenting process and to assess perceived ability of adolescent girls to offer self-test kits to their sexual partners was evaluated. The study will be conducted in 4 sequential phases, each phase informing the subsequent one:

  • understanding of the consenting document and process by participants who have not reached the legal age of consent (Phase I);

  • determining whether adolescent girls can offer oral HIV self-tests to their partners (Phase II);

  • assess whether oral self-testing improves uptake of HIV testing among partners of adolescent girls (Phase III);

  • document adverse events associated with offering oral self-testing to sexual partners of adolescents (Phase IV); and

  • qualitatively explore the experiences of adolescents in offering self-test kits to their partners (Phase V).

Study Contact: Kawango Agot (Email: kawango@impact-rdo.org )
Principal Investigator:Harsha Thirumurthy, PhD (University of North Carolina at Chapel Hill, NC, USA) and Kawango Agot, PhD, MPH (Impact Research and Development Organization, IRDO)
Co-Investigators:Gift-Noelle Wango, MPH, BSSN, CCRN (Centre for Disease Control and Prevention, Kisumu, Kenya), Sue Napierala Mavedzenge, PhD (RTI International, CA, USA), Samuel Masters, MPH, PhD(c) (PhD Student and research analyst, University of North Carolina at Chapel Hill, NC, USA), Spala Ohaga, MSc, PhD (Head of Programs, Impact Research and Development Organization, Kisumu, Kenya), Rose Oyoo, B.A, MA (Study Coordinator, Impact Research and Development Organization, Kisumu, Kenya)
Funding:University of North Carolina at Chapel Hill

Our Partners